New findings show that Ibrance has the potential to help patients with brain metastases that harbor a CDK pathway alteration.
Dr. Pamela Brastianos
Advertisement
Articles by Dr. Pamela Brastianos
Advertisement
Latest Updated Articles
Ibrance Shows Promise in Patients with Brain Metastases Who Harbor a CDK Pathway AlterationPublished: December 19th 2019 | Updated:
Advertisement
Advertisement
Trending on CURE
1
New Combination Treatment Approach Studied in Pancreatic Cancer
2
Why Is Lung Health Key to Survivorship After Cancer Treatment?
3
U.S. Soccer Legend Kasey Keller Reveals Lymphoma Journey
4
The Power of Personalized Care in Breast Cancer Treatment
5